<DOC>
	<DOCNO>NCT02688049</DOCNO>
	<brief_summary>The purpose study assess efficacy safety mesenchymal stem cell neural stem cell combine NeuroRegen scaffold transplantation patient spinal cord injury .</brief_summary>
	<brief_title>NeuroRegen Scaffold™ Combined With Stem Cells Chronic Spinal Cord Injury Repair</brief_title>
	<detailed_description />
	<mesh_term>Wounds Injuries</mesh_term>
	<mesh_term>Spinal Cord Injuries</mesh_term>
	<criteria>1 . Male female , 1865 year old . 2 . Completely spinal cord injury cervical thoracic level ( C5T12 ) . 3 . Classification ASIA A significant improvement . 4 . Patients sign informed consent . 5 . Ability willingness regular visit hospital follow protocol Procedures . 1 . A current diagnosis primary disease affect limb function ( e.g. , trauma , infection , tumor , congenital malformation , peripheral muscular dystrophy , Huntington 's disease , Parkinson 's disease ) . 2 . Serious complication ( e.g. , hydronephrosis due renal insufficiency , severe bedsore ( Ⅲ° ) , low extremity venous thrombosis , severe myositis ossificans ) . 3 . History life threaten allergic immunemediated reaction . 4 . Clinically significant abnormality routine laboratory examination ( hematology , electrolytes , biochemistry , liver kidney function test , urinanalysis ) . 5 . History mental illness suicide risk , history epilepsy central nervous system disorder . 6 . Severe arrhythmia ( e.g. , ventricular tachycardia , frequent superventricular tachycardia , atrial fibrillation , atrial flutter ) cardiac degree II conduction abnormality display via 12lead ECG . 7 . Lactating pregnant woman . 8 . Alcohol drug abuse /dependence . 9 . Participated clinical trial within 3 month enrollment . 10 . A drug treatment know cause effect central nervous system past four week . 11 . A drug treatment know cause major organ system toxicity past four week . 12 . Poor compliance , difficult complete study . 13 . Any condition might increase risk subject interfere clinical trial .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>February 2016</verification_date>
</DOC>